RU2219181C2 - Кристаллические макролиды, способы их получения и фармацевтическая композиция на их основе - Google Patents

Кристаллические макролиды, способы их получения и фармацевтическая композиция на их основе Download PDF

Info

Publication number
RU2219181C2
RU2219181C2 RU2000101826/04A RU2000101826A RU2219181C2 RU 2219181 C2 RU2219181 C2 RU 2219181C2 RU 2000101826/04 A RU2000101826/04 A RU 2000101826/04A RU 2000101826 A RU2000101826 A RU 2000101826A RU 2219181 C2 RU2219181 C2 RU 2219181C2
Authority
RU
Russia
Prior art keywords
compound
formula
crystalline form
temperature
crystalline
Prior art date
Application number
RU2000101826/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2000101826A (ru
Inventor
Корнелиа ДОЗЕНБАХ
Максимилиан ГРАССБЕРГЕР
Отто ХАРТМАНН
Амарилла ХОРВАТ
Жан-Поль МУТС
Герхард ПЕНН
Забине ПФЕФФЕР
Дирк ВИККХУЗЕН
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10815103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2219181(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of RU2000101826A publication Critical patent/RU2000101826A/ru
Application granted granted Critical
Publication of RU2219181C2 publication Critical patent/RU2219181C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Metallurgy (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2000101826/04A 1997-06-30 1998-06-26 Кристаллические макролиды, способы их получения и фармацевтическая композиция на их основе RU2219181C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9713730.1A GB9713730D0 (en) 1997-06-30 1997-06-30 Organic compounds
GB9713730.1 1997-06-30

Publications (2)

Publication Number Publication Date
RU2000101826A RU2000101826A (ru) 2001-09-27
RU2219181C2 true RU2219181C2 (ru) 2003-12-20

Family

ID=10815103

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000101826/04A RU2219181C2 (ru) 1997-06-30 1998-06-26 Кристаллические макролиды, способы их получения и фармацевтическая композиция на их основе

Country Status (31)

Country Link
US (1) US6423722B1 (enExample)
EP (1) EP0994880B1 (enExample)
JP (2) JP3880634B2 (enExample)
KR (1) KR100399765B1 (enExample)
CN (1) CN1139595C (enExample)
AR (1) AR017754A1 (enExample)
AT (1) ATE287410T1 (enExample)
AU (1) AU739211B2 (enExample)
BR (1) BR9810956A (enExample)
CA (1) CA2290412C (enExample)
CO (1) CO4940463A1 (enExample)
CZ (1) CZ297244B6 (enExample)
DE (1) DE69828692T2 (enExample)
DK (1) DK0994880T3 (enExample)
ES (1) ES2236922T3 (enExample)
GB (1) GB9713730D0 (enExample)
HU (1) HU227755B1 (enExample)
ID (1) ID24897A (enExample)
IL (1) IL132761A0 (enExample)
MY (1) MY118718A (enExample)
NO (1) NO312765B1 (enExample)
NZ (1) NZ500994A (enExample)
PE (1) PE97699A1 (enExample)
PL (1) PL192761B1 (enExample)
PT (1) PT994880E (enExample)
RU (1) RU2219181C2 (enExample)
SK (1) SK285665B6 (enExample)
TR (1) TR199903189T2 (enExample)
TW (1) TW552264B (enExample)
WO (1) WO1999001458A1 (enExample)
ZA (1) ZA985655B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
ATE450535T1 (de) * 2003-09-03 2009-12-15 Glaxo Group Ltd Neues verfahren zur herstellung von pleuromutilinderivaten
SI1734927T1 (sl) * 2004-04-08 2012-09-28 Meda Pharma S A R L Pimekrolimusni penjen sestavek, ki vsebuje heksilenglikol, po izbiri oleil alkohol, dimetilizosorbid in/ali srednjeveriĹľne trigliceride
DE602005021684D1 (de) * 2004-12-01 2010-07-15 Teva Gyogyszergyar Zartkoeruen Verfahren zur herstellung von pimecrolimus
CA2668134A1 (en) * 2006-11-06 2008-05-15 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
WO2008073757A1 (en) * 2006-12-07 2008-06-19 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
EP3064230B1 (en) 2009-07-10 2019-04-10 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
JP5933434B2 (ja) 2009-07-17 2016-06-08 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 薬剤送達バルーンの製造方法
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013022458A1 (en) * 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
CN105102967B (zh) * 2013-03-15 2018-10-12 生物传感器国际集团有限公司 雷帕霉素衍生物的纯化
EP3178824A1 (en) 2015-12-08 2017-06-14 Medichem, S.A. Process for preparing pimecrolimus
KR102592374B1 (ko) * 2017-05-01 2023-10-25 메다 파마 게엠베하 운트 코. 카게 조질의 아스코마이신을 정제된 피메크롤리무스로 전환하는 방법
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease
WO2024209038A1 (en) 2023-04-06 2024-10-10 Premark Pharma Gmbh Use of pimecrolimus for the treatment of dry eye in patients characterized by a corneal staining score of 4 or 5 on the oxford grading scale

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0427680A1 (en) * 1989-11-09 1991-05-15 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
CY1306A (en) 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
JP2728482B2 (ja) * 1989-01-26 1998-03-18 協和醗酵工業株式会社 マクロライド系抗生物質の精製法
JPH089630B2 (ja) 1989-07-10 1996-01-31 ヘマ・ソシエダード・アノニマ 有機化合物の、または関連する改善
EP0594600A1 (en) * 1990-03-13 1994-05-04 FISONS plc Immunosuppressive macrocyclic compounds
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
ES2100291T3 (es) 1991-07-30 1997-06-16 Ajinomoto Kk Cristales de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina y metodos para prepararlos.
US5247076A (en) 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5221740A (en) 1992-01-16 1993-06-22 American Home Products Corporation Oxepane isomers of rapamycin useful as immunosuppressive agents
UA41884C2 (uk) * 1993-11-05 2001-10-15 Амерікан Хоум Продактс Корпорейшн Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів
WO1995022390A1 (en) * 1994-02-22 1995-08-24 Curators Of The University Of Missouri Macrocyclic antibiotics as separation agents
EP0848717A1 (en) * 1995-08-24 1998-06-24 Merck & Co., Inc. Process for the preparation of imidazolyl macrolide immunosuppressants
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0427680A1 (en) * 1989-11-09 1991-05-15 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity

Also Published As

Publication number Publication date
AR017754A1 (es) 2001-10-24
JP2006151999A (ja) 2006-06-15
PL192761B1 (pl) 2006-12-29
IL132761A0 (en) 2001-03-19
CA2290412A1 (en) 1999-01-14
ZA985655B (en) 1998-12-30
NZ500994A (en) 2001-08-31
HK1028597A1 (en) 2001-02-23
US6423722B1 (en) 2002-07-23
SK186699A3 (en) 2000-05-16
AU739211B2 (en) 2001-10-04
GB9713730D0 (en) 1997-09-03
KR20010020423A (ko) 2001-03-15
MY118718A (en) 2005-01-31
CZ297244B6 (cs) 2006-10-11
CZ474099A3 (cs) 2000-04-12
ATE287410T1 (de) 2005-02-15
HUP0003053A2 (hu) 2001-02-28
KR100399765B1 (ko) 2003-09-29
DE69828692D1 (de) 2005-02-24
HU227755B1 (en) 2012-02-28
ES2236922T3 (es) 2005-07-16
EP0994880A1 (en) 2000-04-26
HUP0003053A3 (en) 2003-03-28
TW552264B (en) 2003-09-11
SK285665B6 (sk) 2007-05-03
CA2290412C (en) 2009-11-10
JP4504323B2 (ja) 2010-07-14
NO995909L (no) 1999-12-02
NO995909D0 (no) 1999-12-02
AU8540998A (en) 1999-01-25
PT994880E (pt) 2005-06-30
PL336719A1 (en) 2000-07-03
CO4940463A1 (es) 2000-07-24
PE97699A1 (es) 1999-10-29
TR199903189T2 (xx) 2000-06-21
NO312765B1 (no) 2002-07-01
DK0994880T3 (da) 2005-05-30
BR9810956A (pt) 2000-09-26
JP2001506279A (ja) 2001-05-15
WO1999001458A1 (en) 1999-01-14
DE69828692T2 (de) 2006-01-12
JP3880634B2 (ja) 2007-02-14
ID24897A (id) 2000-08-31
EP0994880B1 (en) 2005-01-19
CN1261365A (zh) 2000-07-26
CN1139595C (zh) 2004-02-25

Similar Documents

Publication Publication Date Title
RU2219181C2 (ru) Кристаллические макролиды, способы их получения и фармацевтическая композиция на их основе
RU2186765C2 (ru) Кристаллические модификации 2-амино-4-(4-фторбензиламино)-1-этоксикарбонил-аминобензола и способ их получения (варианты)
ES2218869T3 (es) Cristales polimorficos de donepezil y un proceso para produccion de dichos cristales.
DK2181988T3 (en) PHARMACEUTICAL COMPOSITIONS BASED ON CRYSTALLINE FORM I OF 5-AZACYTIDINE
RU99118590A (ru) Модификации 2-амино-4-(4-фторбензиламино)-1-этоксикарбонил-аминобензола (варианты), способы их получения (варианты), применение, лекарственное средство на их основе
HU186845B (en) Process for producing new erythromycin compounds and pharmaceutical compositions containing them as active agents
JPH0443070B2 (enExample)
RU2000102914A (ru) Кристаллическая модифицированная форма n-фенил-2-пиримидинаминового производного, способы ее получения и ее применение
O'Connor et al. Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac
RU2000101826A (ru) Кристаллические макролиды и способ их получения
KR100431431B1 (ko) 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
PT93488B (pt) Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina
JP5190259B2 (ja) ８−シアノ−１−シクロプロピル−７−（１ｓ，６ｓ−２，８−ジアザビシクロ［４．３．０］ノナン−８−イル）−６−フルオロ−１，４−ジヒドロ−４−オキソ−３−キノリンカルボン酸の新規結晶形態物
US6544977B1 (en) Crystalline forms of 1s-[1-alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl)carbonyl]amino]octahydro-6h-pyridazino [1,2-a] [1,2] diazepin-1-carboxamide
PL200527B1 (pl) Sposób otrzymywania 9-deoksy-9(Z)-hydroksyiminoerytromycyny A
WO2016034602A1 (en) Solid forms of (2s,4r)-4-[4-(1-methyl-1h-pyrazol-4-yl)-2-trifluoromethyl-benzenesulfonyl]-1-(1-trifluoromethyl-cyclopropanecarbonyl)-pyrrolidine-2-carboxylic acid (1-cyano-cyclopropyl)-amide
TH40675A (th) แม็คโครไลด์ที่เป็นผลึก
TH50813B (th) แม็คโครไลด์ที่เป็นผลึก
PL195879B1 (pl) Sposób wytwarzania krystalicznego dihydratu azytromycyny
KR960010652A (ko) 결정성 토실산 썰타미실린 2수화물의 제조방법

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20131029